Essen Stroke Risk Score (ESRS) for predicting (fatal and non-fatal) stroke - Evidencio
Essen Stroke Risk Score (ESRS) for predicting (fatal and non-fatal) stroke
The Essen stroke risk score predicts the 1-year risk of recurrent (fatal and non-fatal) stroke on a 10-point scale.
Research authors: CAPRIE steering committee.
Version: 1.16
  • Public
  • Cardiology
  • {{ modelType }}
  • Details
  • Validate algorithm
  • Save input
  • Load input
Display
Units

{{section.title}}

Calculate the result

Set more parameters to perform the calculation

1-year risk of (fatal and non-fatal) stroke: %

{{ resultSubheader }}
{{ chart.title }}
Result interval {{ additionalResult.min }} to {{ additionalResult.max }}

Conditional information

This model calculates the 1-year risk of recurrent (fatal and non-fatal) stroke on a 10-point scale. It was derived from the data subset of 6341 patients with ischemic stroke in the large-scale Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) trial.1,2

The model was validated in patients with recent cerebrovascular events using the data set of the European Stroke Prevention Study II (ESPS-2).3,4 In addition, it was externally validated in the large outpatient population of the REduction of Atherothrombosis for Continued Health (REACH) Registry.5

References:

  1. CAPRIE Steering Committee. A randomised, blinded, trial of Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE). Lancet.1996;348:1329-1339.
  2. Diener HC, Ringleb PA, Savi P. Clopidogrel for the secondary prevention of stroke. Exp Opin Pharmacother. 2005;6:755-764.
  3. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1-13.
  4. Diener HC. Modified-release dipyridamole combined with aspirin for secondary stroke prevention. Aging Health. 2005;1:19-26.
  5. Weimar C, Diener HC, Alberts MJ, et al. The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the Reduction of Atherotrombosis for Continued Health (REACH) registry. Stroke. 2009;40(2)350-4.

{{ file.classification }}
PRO
Note
Notes are only visible in the result download and will not be saved by Evidencio

This algorithm is provided for educational, training and information purposes. It must not be used to support medical decision making, or to provide medical or diagnostic services. Read our full disclaimer.

Underlying algorithms Part of
Comments
Comment
Please enter a comment
Comments are visible to anyone

Algorithm feedback

No feedback yet 1 Comment {{ model.comments.length }} Comments
On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
{{ comment.content }}
logo

Please sign in to enable Evidencio print features

In order to use the Evidencio print features, you need to be logged in.
If you don't have an Evidencio Community Account you can create your free personal account at:

https://www.evidencio.com/registration

Printed results - Examples {{ new Date().toLocaleString() }}


Evidencio Community Account Benefits


With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.


Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.
Evidencio v3.35 © 2015 - 2025 Evidencio. All Rights Reserved